Abbott Laboratories | ABT
Healthcare•$223.73B
Article
Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal?
Sentiment:0
View OriginalBenzinga•Dec 05, 2025•18:33
Analyst RoundupExpert OpinionSector Analysis
Article
FDA Warns Against Abbott Glucose Monitor Sensors After Reports Of Over 700 Injuries, 7 Deaths
Sentiment:2
View OriginalBenzinga•Dec 05, 2025•16:36
Breaking News/EventPharma/Biotech ClinicalRegulatory/Policy
Benzinga•Dec 02, 2025•14:03
Expert OpinionSector AnalysisTech Product Launch
Benzinga•Dec 02, 2025•14:01
Expert OpinionPrice Target UpdateSector Analysis
Overview for ABT
Price chart and key metrics will appear here.